Improving the earlier detection
of aggressive prostate cancer with our Precision Prostate Cancer Pathway
A tissue test to improve the identification of men at risk for undetected clinically significant prostate cancer after a negative biopsy.
Localized Prostate Cancer
A genomic assay designed for men with low-, intermediate-, and high-risk localized prostate cancer to help guide treatment decisions at the time of diagnosis.
A highly predictive urine test to help identify men at risk for aggressive prostate cancer prior to initial biopsy.